$1,798.00 travel Payment -- Allergan (AbbVie) to Dr. Matthew Walker

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Allergan (AbbVie) made a $1.8K travel payment to Matthew Walker, a Gastroenterology specialist in City, VA. The payment was associated with Dupixent. The payment of $1798 to Dr. Matthew Walker was for travel and lodging expenses related to Dupixent. This payment was made by Allergan (AbbVie) on June 30, 2025. The payment was associated with the drug Dupixent, indicating a potential educational or promotional purpose.

Patient Guidance: What This Payment Means for You

If you are a patient, this payment may indicate your doctor attended an event or meeting related to a medication. Discuss any questions about your treatment with your doctor. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Travel and lodging payments to Gastroenterologists are common for educational events or conferences related to specific drugs like Dupixent.

Regulatory Context: Sunshine Act Requirements

Payments for travel and lodging must be reported under the Open Payments program if they meet reporting thresholds, ensuring transparency in physician-pharma relationships.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharmaceutical-payments
• physician-compensation
• travel-expenses
• gastroenterology
• dupixent
• allergan-abbvie

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $1.8K payment for?

This was a travel payment of $1.8K from Allergan (AbbVie) to Matthew Walker, categorized as "Travel and Lodging". It was associated with Dupixent. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Matthew Walker accept pharmaceutical money?

Yes, Matthew Walker received this $1.8K payment from Allergan (AbbVie). Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Matthew Walker's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $1.8K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Gastroenterology?

To compare this payment against Gastroenterology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Gastroenterology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Matthew Walker's relationship with Allergan (AbbVie)?

The payment covers travel and lodging, suggesting an event or meeting attended by the physician. This $1.8K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Gastroenterology?

The specific drug, Dupixent, is mentioned, which could be for educational purposes or product promotion.

What should patients do after learning about this payment?

If you are a patient, this payment may indicate your doctor attended an event or meeting related to a medication. Discuss any questions about your treatment with your doctor.

What else should I know about this travel payment?

The payment date is in the future (2025-06-30), which is unusual for reported historical data.

Related Reports

• View Dr. Matthew Walker's full payment report
• Allergan (AbbVie) full spending report
• Browse all Gastroenterology payments
• Browse all payments in Virginia
• Search for other payments